Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...
If results suggest iron overload, genetic testing can confirm the diagnosis. But the challenge is knowing who to test. Because symptoms are often vague and the condition is still perceived as rare, ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...
The Lagos State Traffic Management Authority (LASTMA) has commenced a statewide enforcement initiative aimed at tackling hazardous practice of vehicular overloading. The General Manager of LASTMA, Mr ...
CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...
WASHINGTON--(BUSINESS WIRE)--Tom Neely, chairman of Oxford Pharmaceuticals, testified Wednesday before the U.S. Senate Special Committee on Aging, urging Congress to recognize generic pharmaceuticals ...
WASHINGTON — Our investigation, Tainted Trust: Inside the Global Medicine Pipeline, reveals how the drugs taken by millions of Americans trace back to factories in India, a system plagued by weak ...
The drug is indicated for the treatment of schizophrenia and for additional maintenance treatment of bipolar disorder. Gavaris added, "It highlights our commitment to expanding our portfolio of ...
The White House said Friday that the Food and Drug Administration's approval of a generic form of mifepristone was just following the law and not a sign of support for the abortion pill. Watch White ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results